Michael Clayman, President & CEO, Director at Flexion Therapeutics, holds 919.90K shares in Flexion Therapeutics (Ticker: FLXN), holds 0.00 shares in Akebia Therapeutics (Ticker: AKBA).
What is the percentage of profitable transactions made by Michael Clayman?
The percentage of profitable transactions made by Michael Clayman is 67%.
What is the average return per transaction made by Michael Clayman?
The average return per transaction made by Michael Clayman is 23.60%.
What stocks does Michael Clayman hold?
Michael Clayman holds: FLXN, AKBA stocks.
What was Michael Clayman’s latest transaction?
Michael Clayman latest transaction was an Uninformative Buy of ―.
What was Michael Clayman's most profitable transaction?
Michael Clayman’s most profitable transaction was an Informative Buy of FLXN stock on May 23, 2016. The return on the trade was 84.80%.
What is Michael Clayman's role in Flexion Therapeutics?
Michael Clayman's role in Flexion Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.